MIBG-131I (meta-iodobenzylguanidine) injection for diagnostic use

Primenaconfirmation in suspected neuroectodermally derived tumours including neuroblastoma, phaeochromocytoma and ganglioneuroma, -staging of the disease,
follow-up of neuroblastoma under chemotherapy, particularly in stage IV and IVs patients,
before and after surgery of the primary tumour, -follow-up after treatment to exclude a sub-clinical relapse, especially in the bone marrow and also in the case of any clinical abnormality during follow- up, particularly bone pain,
before planning MIBG therapy
Farmaceutski obliksolution for injection
Veličina pakovanja10 ml glass vial, closed with rubber stopper and aluminum cap, placed in a lead container. The vial contains a volume of solution corresponding to the activity determined on the calibration day.
Sadržaj po bočicimeta-iodobenzylguanidine (131I) activities of 10 – 74 MBq/ml at time of calibration
ascorbic acid
Karakteristike rastvorapH 3.5 – 8.0
radionuclidic purity: > 99.9 %
radiochemical purity: > 94 %
clear, colorless or slightly yellow solution
Kalibracijaat the user's request
Rok upotrebe14 days from the production date (expiry date is stated on the label)
Čuvanjein a refrigerator (2-8 ºC), protect from light
Isporukana on request